AUBREY KINSMAN: Open Payments
NPI 1518108158 · PINEHURST, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,884 in 46 payments from 15 companies in 2025. Trend: 2023 $249 · 2024 $942 · 2025 $1,884
Food & beverage: $1,296Travel & lodging: $588
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 15 | $1,124 |
| BridgeBio Pharma, Inc. | 4 | $166 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $110 |
| Amgen Inc. | 6 | $110 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $58 |
| Merck Sharp & Dohme LLC | 2 | $51 |
| PFIZER INC. | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| ABIOMED | 1 | $39 |
| CVRx, Inc. | 1 | $29 |
Products named: CARDIOMEMS, Attruby, Kerendia, REPATHA, JARDIANCE, LEQVIO, KEYTRUDA, Barostim Neo System.
Industry payments across NC — which companies pay providers there.
